Literature DB >> 23730699

Nanobodies and their potential applications.

Gholamreza Hassanzadeh-Ghassabeh1, Nick Devoogdt, Pieter De Pauw, Cécile Vincke, Serge Muyldermans.   

Abstract

Nanobodies are recombinant, antigen-specific, single-domain, variable fragments of camelid heavy chain-only antibodies. The innate supremacy of nanobodies as a renewable source of affinity reagents, together with their high production yield in a broad variety of expression systems, minimal size, great stability, reversible refolding and outstanding solubility in aqueous solutions, and ability to specifically recognize unique epitopes with subnanomolar affinity, have combined to make them a useful class of biomolecules for research and various medical diagnostic and therapeutic applications. This article speculates on a number of technological innovations that might be introduced in the nanobody identification platform to streamline the generation of more potent nanobodies and to expand their application range.

Mesh:

Substances:

Year:  2013        PMID: 23730699     DOI: 10.2217/nnm.13.86

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  83 in total

1.  Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.

Authors:  Abhineet S Sheoran; Igor P Dmitriev; Elena A Kashentseva; Ocean Cohen; Jean Mukherjee; Michelle Debatis; Jonathan Shearer; Jacqueline M Tremblay; Gillian Beamer; David T Curiel; Charles B Shoemaker; Saul Tzipori
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Exploiting Nanobodies in the Detection and Quantification of Human Growth Hormone via Phage-Sandwich Enzyme-Linked Immunosorbent Assay.

Authors:  Hossam Murad; Jana Mir Assaad; Rasha Al-Shemali; Abdul Qader Abbady
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-30       Impact factor: 5.555

3.  Camelid nanobodies with high affinity for broad bean mottle virus: a possible promising tool to immunomodulate plant resistance against viruses.

Authors:  Ahmed Ghannam; Safa Kumari; Serge Muyldermans; Abdul Qader Abbady
Journal:  Plant Mol Biol       Date:  2015-02-04       Impact factor: 4.076

4.  Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.

Authors:  Amanda Sparkes; Patrick De Baetselier; Lea Brys; Inês Cabrito; Yann G-J Sterckx; Steve Schoonooghe; Serge Muyldermans; Geert Raes; Richard Bucala; Peter Vanlandschoot; Jo A Van Ginderachter; Benoît Stijlemans
Journal:  FASEB J       Date:  2018-01-25       Impact factor: 5.191

5.  Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Authors:  Andrew W Woodham; Ross W Cheloha; Jingjing Ling; Mohammad Rashidian; Stephen C Kolifrath; Maia Mesyngier; Joao N Duarte; Justin M Bader; Joseph G Skeate; Diane M Da Silva; W Martin Kast; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2018-05-23       Impact factor: 11.151

Review 6.  Single-molecule labeling for studying trafficking of renal transporters.

Authors:  Ankita Bachhawat Jaykumar; Paulo S Caceres; Pablo A Ortiz
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-25

7.  A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.

Authors:  Mahtab Moayeri; Clinton E Leysath; Jacqueline M Tremblay; Catherine Vrentas; Devorah Crown; Stephen H Leppla; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

8.  Interactions between metal-binding domains modulate intracellular targeting of Cu(I)-ATPase ATP7B, as revealed by nanobody binding.

Authors:  Yiping Huang; Sergiy Nokhrin; Gholamreza Hassanzadeh-Ghassabeh; Corey H Yu; Haojun Yang; Amanda N Barry; Marco Tonelli; John L Markley; Serge Muyldermans; Oleg Y Dmitriev; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

9.  Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager.

Authors:  Martin Felices; Todd R Lenvik; Behiye Kodal; Alexander J Lenvik; Peter Hinderlie; Laura E Bendzick; Dawn K Schirm; Michael F Kaminski; Ron T McElmurry; Melissa A Geller; Craig E Eckfeldt; Daniel A Vallera; Jeffrey S Miller
Journal:  Cancer Immunol Res       Date:  2020-07-13       Impact factor: 11.151

Review 10.  Biosensors for whole-cell bacterial detection.

Authors:  Asif Ahmed; Jo V Rushworth; Natalie A Hirst; Paul A Millner
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.